Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability

Abstract

Polymorphonuclear leukocyte infiltration into tissues in host defense and inflammatory disease causes increased vascular permeability and edema formation through unknown mechanisms. Here, we report the involvement of a paracrine mechanism in neutrophil-evoked alteration in endothelial barrier function. We show that upon neutrophil adhesion to the endothelial lining, leukocytic β2 integrin signaling triggers the release of neutrophil-borne heparin-binding protein (HBP), also known as CAP37/azurocidin, a member of the serprocidin family of neutrophil cationic proteins. HBP induced Ca++-dependent cytoskeletal rearrangement and intercellular gap formation in endothelial-cell monolayers in vitro, and increased macromolecular efflux in microvessels in vivo. Moreover, selective inactivation of HBP prevented the neutrophils from inducing endothelial hyperpermeability. Our data suggest a fundamental role of neutrophil-derived HBP in the vascular response to neutrophil trafficking in inflammation. Targeting this molecule in inflammatory disease conditions offers a new strategy for prevention of endothelial barrier dysfunction caused by misdirected leukocyte activation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Immunorecognition of HBP released from activated PMN.
Figure 2: Kinetics of changes in EC monolayer permeability in response to stimulation with rHBP.
Figure 3: HBP triggers macromolecular leakage in vivo and active cytoskeletal rearrangement in cultured ECs.
Figure 4: Antibodies against HBP and dextran sulfate (DxSO4) inhibit HBP- and PMN-evoked increase in EC permeability.
Figure 5: Involvement of neutrophil-derived granule proteins in PMN-evoked increase in EC permeability.

Similar content being viewed by others

References

  1. Michel, C.C. & Curry, F.E. Microvascular permeability. Physiol. Rev. 79, 703–761 (1999)

    Article  CAS  Google Scholar 

  2. Wedmore, C.V. & Williams, T.J. Control of vascular permeability by polymorphonuclear leukocytes in inflammation. Nature 289, 646–650 (1981).

    Article  CAS  Google Scholar 

  3. Arfors, K.E. et al. A monoclonal antibody to the membrane glycoprotein complex CD18 inhibits polymorphonuclear leukocyte accumulation and plasma leakage in vivo. Blood 69, 338–340 (1987).

    CAS  PubMed  Google Scholar 

  4. Kaslovsky, R.A. et al. Pulmonary edema induced by phagocytosing neutrophils. Protective effect of monoclonal antibody against phagocyte CD18 integrin. Circ. Res. 67, 795–802 (1990).

    Article  CAS  Google Scholar 

  5. Edens, H.A. & Parkos, C.A. Modulation of epithelial and endothelial paracellular permeability by leukocytes. Adv. Drug Deliver. Rev. 41, 315–328 (2000).

    Article  CAS  Google Scholar 

  6. Gautam, N., Herwald, H., Hedqvist, P. & Lindbom, L. Signaling via beta(2) integrins triggers neutrophil-dependent alteration in endothelial barrier function. J. Exp. Med. 191, 1829–1839 (2000).

    Article  CAS  Google Scholar 

  7. Flodgaard, H. et al. Covalent structure of two novel neutrophile leucocyte-derived proteins of porcine and human origin: neutrophile elastase homologues with strong monocyte and fibroblast chemotactic activities. Eur. J. Biochem. 197, 535–547 (1991).

    Article  CAS  Google Scholar 

  8. Gabay, J.E. et al. Antibiotic proteins of human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 86, 5610–5614 (1989).

    Article  CAS  Google Scholar 

  9. Pereira, H.A., Shafer, W.M., Pohl, J., Martin, L.E. & Spitznagel, J.K. CAP37, a human neutrophil-derived chemotactic factor with monocyte specific activity. J. Clin. Invest. 85, 1468–1476 (1990).

    Article  CAS  Google Scholar 

  10. Borregaard, N. & Cowland, J.B. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood 89, 3503–3521 (1997).

    CAS  PubMed  Google Scholar 

  11. Petersen, L.C., Birktoft, J.J. & Flodgaard H. Binding of bovine pancreatic trypsin inhibitor to heparin binding protein/CAP37/azurocidin. Interaction between a Kunitz-type inhibitor and a proteolytically inactive serine proteinase. Eur. J. Biochem. 214, 271–279 (1993).

    Article  CAS  Google Scholar 

  12. Kastrup, J.S. et al. Two mutants of human heparin binding protein (CAP37): Toward the understanding of the nature of lipid A/LPS and BPTI binding. Proteins 42, 442–451 (2001).

    Article  CAS  Google Scholar 

  13. Iversen, L.F. et al. Structure of HBP, a multifunctional protein with a serine proteinase fold. Nature Struct. Biol. 4, 265–268 (1997).

    Article  CAS  Google Scholar 

  14. Nicholls, A., Sharp, K.A. & Honig, B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11, 281–296 (1991).

    Article  CAS  Google Scholar 

  15. Henson, P.M. & Johnston, R.B. Jr. Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J. Clin. Invest. 79, 669–674 (1987).

    Article  CAS  Google Scholar 

  16. Dallegri, F. & Ottonello, L. Tissue injury in neutrophilic inflammation. Inflamm. Res. 46, 382–391 (1997).

    Article  CAS  Google Scholar 

  17. Pereira, H.A., Erdem, I., Pohl, J. & Spitznagel, J.K. Synthetic bactericidal peptide based on CAP37: a 37-kD human neutrophil granule-associated cationic antimicrobial protein chemotactic for monocytes. Proc. Natl. Acad. Sci. USA 90, 4733–4737 (1993).

    Article  CAS  Google Scholar 

  18. Olofsson, A.M. et al. Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis. J. Clin. Invest. 104, 885–894 (1999).

    Article  CAS  Google Scholar 

  19. Chertov, O. et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271, 2935–2940 (1996).

    Article  CAS  Google Scholar 

  20. Pereira, H.A. CAP37, a neutrophil-derived multifunctional inflammatory mediator. J. Leukoc. Biol. 57, 805–812 (1995).

    Article  CAS  Google Scholar 

  21. Morgan, J.G. et al. Cloning of the cDNA for the serine protease homolog CAP37/azurocidin, a microbicidal and chemotactic protein from human granulocytes. J. Immunol. 147, 3210–3214 (1991).

    CAS  PubMed  Google Scholar 

  22. Almeida, R.P., Melchior, M., Campanelli, D., Nathan, C. & Gabay, J.E. Complementary DNA sequence of human neutrophil azurocidin, an antibiotic with extensive homology to serine proteases. Biochem. Biophys. Res. Commun. 177, 688–695 (1991).

    Article  CAS  Google Scholar 

  23. Aveskogh, M., Lutzelschwab, C., Huang, M.R. & Hellman, L. Characterization of cDNA clones encoding mouse proteinase 3 (myeloblastine) and cathepsin G. Immunogenetics 46, 181–191 (1997).

    Article  CAS  Google Scholar 

  24. Gautam, N., Hedqvist, P. & Lindbom, L. Kinetics of leukocyte-induced changes in endothelial barrier function. Br. J. Pharmacol. 125, 1109–1114 (1998).

    Article  CAS  Google Scholar 

  25. Rosengren, S. & Arfors, K.E. Polycations induce microvascular leakage of macromolecules in hamster cheek pouch. Inflammation 15, 159–172 (1991).

    Article  CAS  Google Scholar 

  26. Peterson, M.W., Stone, P. & Shasby, D.M. Cationic neutrophil proteins increase transendothelial albumin movement. J. Appl. Physiol. 62, 1521–1530 (1987).

    Article  CAS  Google Scholar 

  27. Peters, D.C. & Noble, S. Aprotinin: an update of its pharmacology and therapeutic use in open heart surgery and coronary artery bypass surgery. Drugs 57, 233–260 (1999).

    Article  CAS  Google Scholar 

  28. Lindmark, A., Garwicz, D., Rasmussen, P.B., Flodgaard, H. & Gullberg, U. Characterization of the biosynthesis, processing, and sorting of human HBP/CAP37/azurocidin. J. Leukoc. Biol. 66, 634–643 (1999).

    Article  CAS  Google Scholar 

  29. Rasmussen, P.B. et al. Characterization of recombinant human HBP/CAP37/azurocidin, a pleiotropic mediator of inflammation-enhancing LPS-induced cytokine release from monocytes. FEBS Lett. 390, 109–112 (1996).

    Article  CAS  Google Scholar 

  30. Raud, J. & Lindbom, L. in Immunopharmacology of the microcirculation. The Handbook of Immunopharmacology (ed. Brain, S.) 127–170 (Academic, London, 1994)

    Google Scholar 

Download references

Acknowledgements

This study was supported by the Swedish Medical Research Council (14X-4342), the Swedish Foundation for Health Care Sciences and Allergy Research (A2001 068), the Swedish National Board for Laboratory Animals, IngaBritt and Arne Lundbergs Foundation, and Karolinska Institutet.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lennart Lindbom.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gautam, N., Maria Olofsson, A., Herwald, H. et al. Heparin-binding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability. Nat Med 7, 1123–1127 (2001). https://doi.org/10.1038/nm1001-1123

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1001-1123

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing